Find information on thousands of medical conditions and prescription drugs.

Optic neuritis

Optic neuritis (or retrobulbar neuritis) is the inflammation of the optic nerve that may cause a complete or partial loss of vision. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
Obesity
Obsessive-compulsive...
Occipital horn syndrome
OCD
Ochronosis
Oculocutaneous albinism,...
Oculopharyngeal muscular...
Odontophobia
Odynophobia
Oikophobia
Olfactophobia
Olivopontocerebellar atrophy
Omenn syndrome
Onchocerciasis
Oncocytoma
Ondine's curse
Opportunistic infections
Oppositional defiant...
Optic atrophy
Optic neuritis
Oral leukoplakia
Ornithosis
Orthostatic intolerance
Osgood-Schlatter disease
Osteitis deformans
Osteoarthritis
Osteochondritis
Osteochondritis dissecans
Osteochondroma
Osteogenesis Imperfecta
Osteomalacia
Osteomyelitis
Osteopetrosis, (generic...
Osteoporosis
Osteosclerosis
Otosclerosis
Otospondylomegaepiphyseal...
Ovarian cancer
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Causes

The optic nerve comprises axons that emerge from the retina of the eye and carry visual information to the primary visual nuclei, most of which is relayed to the occipital cortex of the brain to be processed into vision.

Inflammation of the optic nerve causes loss of vision usually due to the swelling and destruction of the myelin sheath covering the optic nerve.

Direct axonal damage may also play a role in nerve destruction in many cases.

Some causes are viral-bacterial infections (e.g. herpes zoster), autoimmune disorders (e.g. lupus) and the inflammation of vessels (vasculitis) nourishing the optic nerve.

Optic neuritis can also emerge as an attendant, first, or sole manifestation of multiple sclerosis.

Symptoms

Major symptoms are sudden loss of vision (partial or complete) and occasionally pain on movement of the eyes. Most patients with optic neuritis may lose their color vision, as well.

On medical examination the head of the optic nerve can easily be visualised by an ophthalmoscope. In many cases, only one eye is affected and patients may not be aware of the loss of color vision until the doctor asks them to close or cover the healthy eye.

Treatment and Prognosis

In most cases, visual functions return to near normal within 8 to 10 weeks, but they may also advance to a complete and permanent state of visual loss.

Therefore, systemic intravenous treatment with corticosteroids, which may quicken the healing of the optic nerve, prevent complete loss of vision, and delay the onset of other multiple sclerosis symptoms, is often recommended. It has been demonstrated that oral administration of corticosteroids in this situation may lead to more recurrent attacks than in non-treated patients (though oral steroids are generally prescribed after the intravenous course, to wean the patient off the medication). This effect of corticosteroids seems to be limited to optic neuritis and has not been observed in other diseases treated with corticosteroids.

Very occasionally, if there is concomittant increased intracranial pressure the sheath around the optic nerve may be cut to decrease the pressure.

When optic neuritis is associated with MRI lesions suggestive of multiple scelrosis (MS) then general immunosuppressive therapy for MS is most often prescribed.

Diagnosis

Optic neuritis is often diagnosed by the neurologist and managed by an ophthalmologist. However, ideally, a neuro-ophthalmologist should be consulted at a major university hospital center.

Read more at Wikipedia.org


[List your site here Free!]


Regaining vision lost to optic neuritis? - through immunoglobulin G therapy
From Inside MS, 9/22/95

Based on preliminary investigations in laboratory animals with EAE, a study was done in a very small number of people with MS suggesting that immunoglobulin, or Ig (a preparation of immune-system proteins), promotes recovery of vision lost to optic neuritis.

The National MS Society funded a pilot study on this therapy, and now a full-scale three-year clinical trial is in progress at the Mayo Clinic at Rochester, Minnesota, funded by the National Institutes of Health. Related studies at Mayo are focused on the use of intravenous Ig to aid recovery of muscle strength.

The optic neuritis therapy involves intravenous infusions of Ig once a day for five days and then once a month for three months. The trial is pen to people whose eyesight grew worse than 20/40 in a recent bout of MS-associated optic neuritis and has not improved after six months.

While most costs are subsidized by the study, a required pre-enrollment consultation must be paid for by the prospective volunteer. For information, call 1-800-FIGHT-MS.

Linomide for Progressive MS

Merits a Large-Scale Study

In a preliminary clinical study in Israel, linomide, a chemical that stimulates production of key immune-system cells, performed better than a dummy drug in slowing the decline in function caused by secondary-progressive MS. This form of MS begins as relapsing-remitting but over time becomes steadily progressive. A multicenter trial in the U.S., sponsored by Pharmacia, a Swedish drug company, will start soon.

Will Treatment Make

Life Better?

To make informed decisions about any therapy, both doctors and people with MS need to know how best to balance clinical benefits, side effects, and quality of life. This topic is under study in several National MS Society-funded projects. A team at Frontier Science and Technology Research Foundation is adapting cancer and AIDS quality-of-life evaluations to MS; a questionnaire on abilities, pain, and other factors has been developed at UCLA; and ways to measure emotional well-being and the quality of life are being field-tested at four U.S. MS Centers.

COPYRIGHT 1995 National Multiple Sclerosis Society
COPYRIGHT 2004 Gale Group

Return to Optic neuritis
Home Contact Resources Exchange Links ebay